Trombofilia, ¿cuándo, qué pruebas y a quién?

Treatment with heparin in those pregnant woman who are thrompbophilic is emphasized. In those patients with thrombosis and hereditary thrombophilia a family study to detect asyntomatic carriers is suggested in order to implement therapy to avoid thrombophilic risk. The thromboembolic venous disease is common and deadly condiition that often causes sudden dead. To known the thrombophilic risk and to make a correct prophylaxis may decrease the incidence.